Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 IN PLASTIC CONTAINER versus DEXTROSE 7 7 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 IN PLASTIC CONTAINER versus DEXTROSE 7 7 IN PLASTIC CONTAINER.
DEXTROSE 5% IN PLASTIC CONTAINER vs DEXTROSE 7.7% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that provides a source of calories and fluid for parenteral nutrition. It increases blood glucose levels and is metabolized to carbon dioxide and water, providing energy. It also serves as a source of water for hydration.
Dextrose is a simple sugar that provides a source of calories and fluid for intravenous administration. It increases blood glucose levels, enhancing cellular metabolism and energy production via the glycolytic pathway and subsequent oxidative phosphorylation.
Intravenous infusion: 500-1000 mL as needed based on fluid and caloric requirements. Typical rate: 100-200 mL/hour for maintenance. Maximum infusion rate: 0.5-0.8 g/kg/hour.
Intravenous infusion. Typical adult dose is 500-1000 mL of 7.7% dextrose solution infused at a rate of 100-200 mL/hour, titrated to clinical response and serum glucose levels.
None Documented
None Documented
Intravenous: 1.5-2.5 hours for glucose clearance; prolonged in renal impairment or diabetes mellitus
30-60 minutes for blood glucose to return to baseline after infusion cessation; clinical context: rapid metabolism via glycolysis.
Renal: negligible as unchanged drug; metabolized to water and carbon dioxide, excreted via lungs (>90%) and urine (glucose normally <0.1%)
Renal: 100% as CO2 and water; no unchanged dextrose excreted in urine under normal conditions.
Category C
Category C
Intravenous Fluid
Intravenous Fluid